Zhang Zhi-Guo, Li Gang, Feng Da-Yun, Zhang Jian, Zhang Jing, Qin Huai-Zhou, Ma Lian-Ting, Gao Guo-Dong, Wu Lin
Department of Neurosurgery and Institute for Functional Brain Disorders, Tangdu Hospital, Xi'an, China E-mail :
Asian Pac J Cancer Prev. 2014;15(1):239-44. doi: 10.7314/apjcp.2014.15.1.239.
Several recent studies have showed that the n-myc downstream regulated gene 2 (NDRG2) is a new tumor suppressor gene, and that it plays an important role in tumor suppression in several cancers or cancer cell lines. However, few studies focused on its function in neuroblastoma cells. In the present investigation, we demonstrated that NDRG2 overexpression inhibited their proliferation. Using a cDNA microarray, we found that overexpression of NDRG2 inhibited the expression of cysteine-rich protein 61 (CYR61), a proliferation related gene. From our research, CYR61 may partially hinder NDRG2-mediated inhibition of cell proliferation. Overexpression of NDRG2 resulted in accumulation of cells in the G1 phase, which was accompanied by upregulation of p21 and p27 and downregulation of CDK4 and cyclin D1. Taken together, these data indicate that NDRG2 inhibits the proliferation of neuroblastoma cells partially through suppression of CYR61. Our findings offer novel insights into the physiological roles of NDRG2 in neuroblastoma cell proliferation, and NDRG2 may prove to be effective candidate for the treatment of children with neuroblastoma.
最近的几项研究表明,N-myc下游调控基因2(NDRG2)是一种新的肿瘤抑制基因,并且它在几种癌症或癌细胞系的肿瘤抑制中发挥重要作用。然而,很少有研究关注其在神经母细胞瘤细胞中的功能。在本研究中,我们证明NDRG2的过表达抑制了它们的增殖。使用cDNA微阵列,我们发现NDRG2的过表达抑制了富含半胱氨酸蛋白61(CYR61)的表达,CYR61是一种与增殖相关的基因。根据我们的研究,CYR61可能部分阻碍NDRG2介导的细胞增殖抑制。NDRG2的过表达导致细胞在G1期积累,这伴随着p21和p27的上调以及CDK4和细胞周期蛋白D1的下调。综上所述,这些数据表明NDRG2部分通过抑制CYR61来抑制神经母细胞瘤细胞的增殖。我们的研究结果为NDRG2在神经母细胞瘤细胞增殖中的生理作用提供了新的见解,并且NDRG2可能被证明是治疗神经母细胞瘤患儿的有效候选药物。